Improving Chemotherapy Dose Calculation
Author Information
Author(s): Gurney H
Primary Institution: Department of Medical Oncology and Palliative Care, Westmead Hospital
Hypothesis
Current body surface area-dosing for chemotherapy leads to significant underdosing in patients.
Conclusion
Inaccurate dosing based on body surface area can lead to a substantial reduction in survival rates for cancer patients.
Supporting Evidence
- Body surface area-dosing can lead to an almost 20% relative reduction in survival for breast cancer patients.
- Underdosing may occur in 30% or more of patients receiving standard chemotherapy regimens.
- The cure rate of cisplatin-based chemotherapy for advanced testicular cancer may be reduced by as much as 10% due to underdosing.
Takeaway
Doctors often use a method to calculate chemotherapy doses based on body size, but this can sometimes give patients too little medicine, making it less effective.
Methodology
The article reviews existing literature and presents guidelines for more accurate chemotherapy dosing.
Potential Biases
Potential bias in the interpretation of existing studies and their applicability to current practices.
Limitations
The study relies on existing data and does not present new experimental results.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website